ID   AOC2_HUMAN              Reviewed;         756 AA.
AC   O75106; A5PKW2; O00120; O75105; Q4TTW5; Q9UNY0;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 2.
DT   28-JUN-2023, entry version 184.
DE   RecName: Full=Retina-specific copper amine oxidase;
DE            Short=RAO;
DE            EC=1.4.3.21 {ECO:0000250|UniProtKB:P19801};
DE   AltName: Full=Amine oxidase [copper-containing];
DE   AltName: Full=Semicarbazide-sensitive amine oxidase;
DE            Short=SSAO;
DE   Flags: Precursor;
GN   Name=AOC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Retina;
RX   PubMed=9119395; DOI=10.1006/geno.1996.4570;
RA   Imamura Y., Kubota R., Wang Y., Asakawa S., Kudoh J., Mashima Y.,
RA   Oguchi Y., Shimizu N.;
RT   "Human retina-specific amine oxidase (RAO): cDNA cloning, tissue
RT   expression, and chromosomal mapping.";
RL   Genomics 40:277-283(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=9722954; DOI=10.1006/geno.1998.5357;
RA   Imamura Y., Noda S., Mashima Y., Kudoh J., Oguchi Y., Shimizu N.;
RT   "Human retina-specific amine oxidase: genomic structure of the gene (AOC2),
RT   alternatively spliced variant, and mRNA expression in retina.";
RL   Genomics 51:293-298(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RA   Zhang X., McIntire W.S.;
RT   "Human copper-containing amine oxidases.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-5; CYS-22; LEU-141;
RP   GLN-273 AND ASP-427.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=12755418; DOI=10.1007/s000110300061;
RA   Heniquez A., Meissonnier G., Visentin V., Prevot D., Carpene C.;
RT   "High expression of semicarbazide-sensitive amine oxidase genes AOC2 and
RT   AOC3, but not the diamine oxidase gene AOC1 in human adipocytes.";
RL   Inflamm. Res. 52:S74-S75(2003).
RN   [9]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=17400359; DOI=10.1016/j.biochi.2007.02.013;
RA   Bour S., Daviaud D., Gres S., Lefort C., Prevot D., Zorzano A.,
RA   Wabitsch M., Saulnier-Blache J.-S., Valet P., Carpene C.;
RT   "Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and
RT   monoamine oxidase in human adipocytes.";
RL   Biochimie 89:916-925(2007).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, TISSUE SPECIFICITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19588076; DOI=10.1007/s00018-009-0076-5;
RA   Kaitaniemi S., Elovaara H., Groen K., Kidron H., Liukkonen J., Salminen T.,
RA   Salmi M., Jalkanen S., Elima K.;
RT   "The unique substrate specificity of human AOC2, a semicarbazide-sensitive
RT   amine oxidase.";
RL   Cell. Mol. Life Sci. 66:2743-2757(2009).
CC   -!- FUNCTION: Has a monoamine oxidase activity with substrate specificity
CC       for 2-phenylethylamine and tryptamine. May play a role in adipogenesis.
CC       May be a critical modulator of signal transmission in retina.
CC       {ECO:0000269|PubMed:17400359, ECO:0000269|PubMed:19588076}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aliphatic amine + H2O + O2 = an aldehyde + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:16153, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17478, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:58001; EC=1.4.3.21;
CC         Evidence={ECO:0000250|UniProtKB:P19801};
CC   -!- COFACTOR:
CC       Name=Cu cation; Xref=ChEBI:CHEBI:23378;
CC         Evidence={ECO:0000250|UniProtKB:P19801};
CC       Note=Binds 1 copper ion per subunit. {ECO:0000250|UniProtKB:P19801};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000250|UniProtKB:P19801};
CC       Note=Binds 2 calcium ions per subunit. {ECO:0000250|UniProtKB:P19801};
CC   -!- COFACTOR:
CC       Name=L-topaquinone; Xref=ChEBI:CHEBI:79027;
CC         Evidence={ECO:0000250|UniProtKB:P19801};
CC       Note=Contains 1 topaquinone per subunit.
CC       {ECO:0000250|UniProtKB:P19801};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.056 mM for tryptamine {ECO:0000269|PubMed:19588076};
CC         KM=0.077 mM for 2-phenylethylamine {ECO:0000269|PubMed:19588076};
CC         KM=0.167 mM for benzylamine {ECO:0000269|PubMed:19588076};
CC         KM=0.178 mM for p-tyramine {ECO:0000269|PubMed:19588076};
CC         KM=1.7 mM for methylamine {ECO:0000269|PubMed:19588076};
CC   -!- SUBUNIT: Homodimer; disulfide-linked (By similarity). Forms a
CC       heterodimer with AOC3, in vitro. {ECO:0000250|UniProtKB:P19801,
CC       ECO:0000269|PubMed:19588076}.
CC   -!- INTERACTION:
CC       O75106; Q13520: AQP6; NbExp=3; IntAct=EBI-17685278, EBI-13059134;
CC       O75106; Q9Y282: ERGIC3; NbExp=3; IntAct=EBI-17685278, EBI-781551;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane
CC       {ECO:0000269|PubMed:19588076}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:19588076}. Note=Present on the surface of the
CC       cells. {ECO:0000269|PubMed:19588076}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000269|PubMed:19588076}. Note=Either not translocated to the
CC       plasma membrane or below detection level.
CC       {ECO:0000269|PubMed:19588076}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Long;
CC         IsoId=O75106-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=O75106-2; Sequence=VSP_006549;
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues with much higher
CC       expression in retina. Isoform 1 and isoform 2 are expressed in adipose
CC       tissue, whereas isoform 1 only seems to be present in thymus, and
CC       isoform 2 only in testis. {ECO:0000269|PubMed:12755418,
CC       ECO:0000269|PubMed:17400359, ECO:0000269|PubMed:19588076}.
CC   -!- INDUCTION: Up-regulated during in vitro adipocyte differentiation.
CC       {ECO:0000269|PubMed:17400359}.
CC   -!- PTM: Topaquinone (TPQ) is generated by copper-dependent autoxidation of
CC       a specific tyrosyl residue. {ECO:0000250|UniProtKB:P12807}.
CC   -!- SIMILARITY: Belongs to the copper/topaquinone oxidase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/aoc2/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D88213; BAA19001.1; -; mRNA.
DR   EMBL; AB012943; BAA32590.1; -; Genomic_DNA.
DR   EMBL; AB012943; BAA32589.1; -; Genomic_DNA.
DR   EMBL; AF081363; AAD39345.1; -; mRNA.
DR   EMBL; DQ060035; AAY43129.1; -; Genomic_DNA.
DR   EMBL; AC016889; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471152; EAW60895.1; -; Genomic_DNA.
DR   EMBL; BC142641; AAI42642.1; -; mRNA.
DR   CCDS; CCDS11443.1; -. [O75106-1]
DR   CCDS; CCDS45690.1; -. [O75106-2]
DR   RefSeq; NP_001149.2; NM_001158.4. [O75106-2]
DR   RefSeq; NP_033720.2; NM_009590.3. [O75106-1]
DR   AlphaFoldDB; O75106; -.
DR   SMR; O75106; -.
DR   BioGRID; 106811; 22.
DR   IntAct; O75106; 5.
DR   STRING; 9606.ENSP00000253799; -.
DR   BindingDB; O75106; -.
DR   ChEMBL; CHEMBL4112; -.
DR   GlyConnect; 1714; 2 N-Linked glycans (1 site).
DR   GlyCosmos; O75106; 5 sites, 2 glycans.
DR   GlyGen; O75106; 5 sites, 2 N-linked glycans (1 site).
DR   iPTMnet; O75106; -.
DR   PhosphoSitePlus; O75106; -.
DR   BioMuta; AOC2; -.
DR   jPOST; O75106; -.
DR   MassIVE; O75106; -.
DR   PaxDb; O75106; -.
DR   PeptideAtlas; O75106; -.
DR   ProteomicsDB; 49761; -. [O75106-1]
DR   ProteomicsDB; 49762; -. [O75106-2]
DR   Antibodypedia; 17156; 84 antibodies from 17 providers.
DR   DNASU; 314; -.
DR   Ensembl; ENST00000253799.8; ENSP00000253799.2; ENSG00000131480.9. [O75106-1]
DR   Ensembl; ENST00000452774.2; ENSP00000406134.1; ENSG00000131480.9. [O75106-2]
DR   GeneID; 314; -.
DR   KEGG; hsa:314; -.
DR   MANE-Select; ENST00000253799.8; ENSP00000253799.2; NM_009590.4; NP_033720.2.
DR   UCSC; uc002ibt.5; human. [O75106-1]
DR   AGR; HGNC:549; -.
DR   CTD; 314; -.
DR   DisGeNET; 314; -.
DR   GeneCards; AOC2; -.
DR   HGNC; HGNC:549; AOC2.
DR   HPA; ENSG00000131480; Low tissue specificity.
DR   MIM; 602268; gene.
DR   neXtProt; NX_O75106; -.
DR   OpenTargets; ENSG00000131480; -.
DR   PharmGKB; PA24839; -.
DR   VEuPathDB; HostDB:ENSG00000131480; -.
DR   eggNOG; KOG1186; Eukaryota.
DR   GeneTree; ENSGT00950000183207; -.
DR   HOGENOM; CLU_015739_1_0_1; -.
DR   InParanoid; O75106; -.
DR   OMA; QDFSKFF; -.
DR   OrthoDB; 5490352at2759; -.
DR   PhylomeDB; O75106; -.
DR   TreeFam; TF314750; -.
DR   BRENDA; 1.4.3.21; 2681.
DR   PathwayCommons; O75106; -.
DR   Reactome; R-HSA-211945; Phase I - Functionalization of compounds.
DR   SABIO-RK; O75106; -.
DR   SignaLink; O75106; -.
DR   BioGRID-ORCS; 314; 15 hits in 1143 CRISPR screens.
DR   GenomeRNAi; 314; -.
DR   Pharos; O75106; Tchem.
DR   PRO; PR:O75106; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; O75106; protein.
DR   Bgee; ENSG00000131480; Expressed in sperm and 103 other tissues.
DR   Genevisible; O75106; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0052594; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; IEA:UniProtKB-EC.
DR   GO; GO:0005507; F:copper ion binding; IBA:GO_Central.
DR   GO; GO:0009055; F:electron transfer activity; TAS:UniProtKB.
DR   GO; GO:0052596; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; IEA:UniProtKB-EC.
DR   GO; GO:0008131; F:primary amine oxidase activity; IBA:GO_Central.
DR   GO; GO:0048038; F:quinone binding; IEA:InterPro.
DR   GO; GO:0052593; F:tryptamine:oxygen oxidoreductase (deaminating) activity; IEA:UniProtKB-EC.
DR   GO; GO:0009308; P:amine metabolic process; IBA:GO_Central.
DR   GO; GO:0006584; P:catecholamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   Gene3D; 3.10.450.40; -; 2.
DR   Gene3D; 2.70.98.20; Copper amine oxidase, catalytic domain; 1.
DR   InterPro; IPR000269; Cu_amine_oxidase.
DR   InterPro; IPR015798; Cu_amine_oxidase_C.
DR   InterPro; IPR036460; Cu_amine_oxidase_C_sf.
DR   InterPro; IPR016182; Cu_amine_oxidase_N-reg.
DR   InterPro; IPR015800; Cu_amine_oxidase_N2.
DR   InterPro; IPR015802; Cu_amine_oxidase_N3.
DR   PANTHER; PTHR10638; COPPER AMINE OXIDASE; 1.
DR   PANTHER; PTHR10638:SF4; RETINA-SPECIFIC COPPER AMINE OXIDASE; 1.
DR   Pfam; PF01179; Cu_amine_oxid; 1.
DR   Pfam; PF02727; Cu_amine_oxidN2; 1.
DR   Pfam; PF02728; Cu_amine_oxidN3; 1.
DR   PRINTS; PR00766; CUDAOXIDASE.
DR   SUPFAM; SSF49998; Amine oxidase catalytic domain; 1.
DR   SUPFAM; SSF54416; Amine oxidase N-terminal region; 2.
DR   PROSITE; PS01164; COPPER_AMINE_OXID_1; 1.
DR   PROSITE; PS01165; COPPER_AMINE_OXID_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Catecholamine metabolism; Cell membrane;
KW   Copper; Cytoplasm; Disulfide bond; Glycoprotein; Membrane; Metal-binding;
KW   Oxidoreductase; Reference proteome; Signal; TPQ.
FT   SIGNAL          1..32
FT                   /evidence="ECO:0000255"
FT   CHAIN           33..756
FT                   /note="Retina-specific copper amine oxidase"
FT                   /id="PRO_0000035671"
FT   ACT_SITE        380
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   ACT_SITE        465
FT                   /note="Schiff-base intermediate with substrate; via
FT                   topaquinone"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         378..388
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         462..467
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         516
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         518
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         525
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         526
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         527
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         568
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         574..581
FT                   /ligand="heparin"
FT                   /ligand_id="ChEBI:CHEBI:28304"
FT                   /evidence="ECO:0000250"
FT   BINDING         659
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         661
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         663
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         669
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         670
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         680
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   MOD_RES         465
FT                   /note="2',4',5'-topaquinone"
FT                   /evidence="ECO:0000250|UniProtKB:P12807"
FT   CARBOHYD        133
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   CARBOHYD        198
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        226
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16853"
FT   CARBOHYD        588
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16853"
FT   CARBOHYD        662
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16853"
FT   DISULFID        398..424
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   DISULFID        730..737
FT                   /evidence="ECO:0000250|UniProtKB:Q16853"
FT   DISULFID        744
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   VAR_SEQ         599..625
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9119395"
FT                   /id="VSP_006549"
FT   VARIANT         5
FT                   /note="I -> V (in dbSNP:rs34230945)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_025022"
FT   VARIANT         22
FT                   /note="Y -> C (in dbSNP:rs34435306)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_025023"
FT   VARIANT         141
FT                   /note="P -> L (in dbSNP:rs35833794)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_025024"
FT   VARIANT         273
FT                   /note="R -> Q (in dbSNP:rs35508987)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_025025"
FT   VARIANT         427
FT                   /note="E -> D (in dbSNP:rs34351794)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_025026"
FT   CONFLICT        181
FT                   /note="E -> D (in Ref. 1 and 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        215..218
FT                   /note="GDRA -> RERT (in Ref. 1 and 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        221..222
FT                   /note="MA -> IG (in Ref. 1)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        610
FT                   /note="H -> Q (in Ref. 1 and 2)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   756 AA;  83673 MW;  10263D8D56D3BD25 CRC64;
     MHLKIVLAFL ALSLITIFAL AYVLLTSPGG SSQPPHCPSV SHRAQPWPHP GQSQLFADLS
     REELTAVMRF LTQRLGPGLV DAAQAQPSDN CIFSVELQLP PKAAALAHLD RGSPPPAREA
     LAIVLFGGQP QPNVSELVVG PLPHPSYMRD VTVERHGGPL PYHRRPVLRA EFTQMWRHLK
     EVELPKAPIF LSSTFNYNGS TLAAVHATPR GLRSGDRATW MALYHNISGV GLFLHPVGLE
     LLLDHRALDP AHWTVQQVFY LGHYYADLGQ LEREFKSGRL EVVRVPLPPP NGASSLRSRN
     SPGPLPPLQF SPQGSQYSVQ GNLVVSSLWS FTFGHGVFSG LRIFDVRFQG ERIAYEVSVQ
     ECVSIYGADS PKTMLTRYLD SSFGLGRNSR GLVRGVDCPY QATMVDIHIL VGKGAVQLLP
     GAVCVFEEAQ GLPLRRHHNY LQNHFYGGLA SSALVVRSVS SVGNYDYIWD FVLYPNGALE
     GRVHATGYIN TAFLKGGEEG LLFGNRVGER VLGTVHTHAF HFKLDLDVAG LKNWVVAEDV
     VFKPVAAPWN PEHWLQRPQL TRQVLGKEDL TAFSLGSPLP RYLYLASNQT NAWGHQRGYR
     IQIHSPLGIH IPLESDMERA LSWGRYQLVV TQRKEEESQS SSIYHQNDIW TPTVTFADFI
     NNETLLGEDL VAWVTASFLH IPHAEDIPNT VTLGNRVGFL LRPYNFFDED PSIFSPGSVY
     FEKGQDAGLC SINPVACLPD LAACVPDLPP FSYHGF
//
